EE255 COST-EFFECTIVENESS ANALYSIS OF SAVOLITINIB VERSUS GLUMETINIB IN THE FIRST-LINE TREATMENT OF CHINESE ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER HARBORING MET EXON 14 SKIPPING MUTATION
作者
高海林,Yue Gao,Yongjia Zhuo,Jianwei Xuan
出处
期刊:Value in Health [Elsevier BV] 日期:2026-06-01卷期号:29 (6): S112-S112